CHRS 总资产历史(2016–2025)
Coherus Oncology, Inc. (CHRS) 各财年年末总资产(来自 SEC 财报)。
$258.3MFY2025 · FY2016 以来:$178.5M → $258.3M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $258.3M | -42.4% |
| FY2024 | $448.5M | -28.8% |
| FY2023 | $629.6M | +30.9% |
| FY2022 | $480.8M | -29.2% |
| FY2021 | $679.3M | -19.3% |
| FY2020 | $841.6M | +105.8% |
| FY2019 | $408.9M | +311.1% |
| FY2018 | $99.5M | -38.8% |
| FY2017 | $162.6M | -8.9% |
| FY2016 | $178.5M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议